Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:731-733

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ridker, P. M.
Right arrow Articles by Hennekens, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ridker, P. M.
Right arrow Articles by Hennekens, C. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Circulation. 1998;98:731-733.)
© 1998 American Heart Association, Inc.


Brief Rapid Communication

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women

Paul M. Ridker, MD; Julie E. Buring, ScD; Jessie Shih, PhD; Mathew Matias, BS; ; Charles H. Hennekens, MD

From the Divisions of Cardiology (P.M.R.) and Preventive Medicine (P.M.R., J.E.B., C.H.H.), Brigham and Women's Hospital, and the Department of Ambulatory Care and Prevention (J.E.B., C.H.H.), Harvard Medical School, Boston, Mass; and Abbott Laboratories, Abbott Park, Ill (M.M., J.S.).

Correspondence to Paul M. Ridker, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115. E-mail pmridker{at}bics.bwh.harvard.edu

Abstract

Background—C-reactive protein (CRP) predicts risk of myocardial infarction (MI) and stroke among apparently healthy men, but in women, virtually no data are available.

Methods and Results—CRP was measured in baseline blood samples from 122 apparently healthy participants in the Women's Health Study who subsequently suffered a first cardiovascular event and from 244 age- and smoking-matched control subjects who remained free of cardiovascular disease during a 3-year follow-up period. Women who developed cardiovascular events had higher baseline CRP levels than control subjects (P=0.0001), such that those with the highest levels at baseline had a 5-fold increase in risk of any vascular event (RR=4.8; 95% CI, 2.3 to 10.1; P=0.0001) and a 7-fold increase in risk of MI or stroke (RR=7.3; 95% CI, 2.7 to 19.9; P=0.0001). Risk estimates were independent of other risk factors, and prediction models that included CRP provided a better method to predict risk than models that excluded CRP (all P values <0.01). In stratified analyses, CRP was a predictor among subgroups of women with low as well as high risk as defined by other cardiovascular risk factors.

Conclusions—In these prospective data among women, CRP is a strong independent risk factor for cardiovascular disease that adds to the predictive value of risk models based on usual factors alone.


Key Words: C-reactive protein • inflammation • cardiovascular diseases




This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
A. B. Pai and T. A. Conner
Oxidative Stress and Inflammation in Chronic Kidney Disease: Role of Intravenous Iron and Vitamin D
Journal of Pharmacy Practice, June 1, 2008; 21(3): 214 - 224.
[Abstract] [PDF]


Home page
Eur Heart JHome page
S. S. Levinson
New cardiovascular risk determinants do exist and are clinically useful
Eur. Heart J., May 2, 2008; 29(10): 1335 - 1335.
[Full Text] [PDF]


Home page
J. Dent. Res.Home page
M. Qvarnstrom, S. Janket, J.A. Jones, P. Nuutinen, A.E. Baird, M.E. Nunn, T.E. Van Dyke, and J.H. Meurman
Salivary Lysozyme and Prevalent Hypertension
J. Dent. Res., May 1, 2008; 87(5): 480 - 484.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. Tzoulaki, M.-R. Jarvelin, A.-L. Hartikainen, M. Leinonen, A. Pouta, M. Paldanius, A. Ruokonen, D. Canoy, U. Sovio, P. Saikku, et al.
Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 birth cohort study
Eur. Heart J., April 9, 2008; (2008) ehn105v1.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
S.-F. Wung and B. E. Aouizerat
Candidate Genes of the 5-Lipoxygenase Pathway in Acute Coronary Syndrome: A Pilot Study
Biol Res Nurs, April 1, 2008; 9(4): 280 - 292.
[Abstract] [PDF]


Home page
Obstet GynecolHome page
S. Cauci, M. Di Santolo, J. F. Culhane, G. Stel, F. Gonano, and S. Guaschino
Effects of Third-Generation Oral Contraceptives on High-Sensitivity C-reactive Protein and Homocysteine in Young Women
Obstet. Gynecol., April 1, 2008; 111(4): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Anuurad, J. Rubin, A. Chiem, R. P. Tracy, T. A. Pearson, and L. Berglund
High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1482 - 1488.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Tabara, H. Osawa, R. Kawamoto, R. Tachibana-Iimori, M. Yamamoto, J. Nakura, T. Miki, H. Makino, and K. Kohara
Reduced High-Molecular-Weight Adiponectin and Elevated High-Sensitivity C-Reactive Protein Are Synergistic Risk Factors for Metabolic Syndrome in a Large-Scale Middle-Aged to Elderly Population: the Shimanami Health Promoting Program Study
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 715 - 722.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. E. Laaksonen, L. Niskanen, K. Nyyssonen, T. A. Lakka, J. A. Laukkanen, and J. T. Salonen
Dyslipidaemia as a predictor of hypertension in middle-aged men
Eur. Heart J., February 28, 2008; (2008) ehn061v1.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Marsik, L. Kazemi-Shirazi, T. Schickbauer, S. Winkler, C. Joukhadar, O. F. Wagner, and G. Endler
C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort
Clin. Chem., February 1, 2008; 54(2): 343 - 349.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. Ulucay, R. Demirbag, R. Yilmaz, D. Unlu, M. Gur, S. Selek, and H. Celik
The Relationship Between Plasma C-Reactive Protein Levels and Presence and Severity of Coronary Stenosis in Patients With Stable Angina
Angiology, January 1, 2008; 58(6): 657 - 662.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kinlay, G. G. Schwartz, A. G. Olsson, N. Rifai, M. Szarek, D. D. Waters, P. Libby, P. Ganz, and for the Myocardial Ischemia Reduction with Aggress
Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 142 - 147.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
H. Blangy, N. Sadoul, B. Dousset, A. Radauceanu, R. Fay, E. Aliot, and F. Zannad
Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction
Europace, September 1, 2007; 9(9): 724 - 729.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. A. Booth and B. R. Lucchesi
Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1408 - H1415.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
A. M. Andrei, R. Fraguas Jr., R. M.S. Telles, T. C.T.F. Alves, C. M.C. Strunz, A. Nussbacher, J. Rays, D. V. Iosifescu, and M. Wajngarten
Major Depressive Disorder and Inflammatory Markers in Elderly Patients With Heart Failure
Psychosomatics, August 1, 2007; 48(4): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D. Tousoulis, C. Antoniades, and C. Stefanadis
Assessing inflammatory status in cardiovascular disease
Heart, August 1, 2007; 93(8): 1001 - 1007.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Dierkes, C. Weikert, K. Klipstein-Grobusch, S. Westphal, C. Luley, M. Mohlig, J. Spranger, and H. Boeing
Plasma pyridoxal-5-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort
Am. J. Clinical Nutrition, July 1, 2007; 86(1): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Grad, M. Golomb, I. Mor-Yosef, N. Koroukhov, C. Lotan, E. R. Edelman, and H. D. Danenberg
Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H489 - H495.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. M. Ridker
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus
J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2129 - 2138.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. G. Yanbaeva, M. A. Dentener, E. C. Creutzberg, G. Wesseling, and E. F. M. Wouters
Systemic Effects of Smoking
Chest, May 1, 2007; 131(5): 1557 - 1566.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. E. King, B. M. Egan, R. F. Woolson, A. G. Mainous III, Y. Al-Solaiman, and A. Jesri
Effect of a High-Fiber Diet vs a Fiber-Supplemented Diet on C-Reactive Protein Level
Arch Intern Med, March 12, 2007; 167(5): 502 - 506.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Ishikawa, Y. Tamura, S. Hoshide, K. Eguchi, S. Ishikawa, K. Shimada, and K. Kario
Low-Grade Inflammation Is a Risk Factor for Clinical Stroke Events in Addition to Silent Cerebral Infarcts in Japanese Older Hypertensives: The Jichi Medical School ABPM Study, Wave 1
Stroke, March 1, 2007; 38(3): 911 - 917.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. Oren, A. R. Erbay, M. Balc, and S. Cehreli
Role of Novel Mediators of Inflammation in Left Ventricular Remodeling in Patients With Acute Myocardial Infarction: Do They Affect the Outcome of Patients?
Angiology, February 1, 2007; 58(1): 45 - 54.
[Abstract] [PDF]


Home page
Circ. Res.Home page
F. Blaschke, Y. Takata, E. Caglayan, A. Collins, P. Tontonoz, W. A. Hsueh, and R. K. Tangirala
A Nuclear Receptor Corepressor-Dependent Pathway Mediates Suppression of Cytokine-Induced C-Reactive Protein Gene Expression by Liver X Receptor
Circ. Res., December 8, 2006; 99(12): e88 - e99.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. S. V. Elkind, W. Tai, K. Coates, M. C. Paik, and R. L. Sacco
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.
Arch Intern Med, October 23, 2006; 166(19): 2073 - 2080.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Endocr. Rev., October 1, 2006; 27(6): 575 - 605.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Marsik, R. Sunder-Plassmann, B. Jilma, F. M. Kovar, C. Mannhalter, O. Wagner, H. Rumpold, and G. Endler
The C-Reactive Protein +1444C/T Alteration Modulates the Inflammation and Coagulation Response in Human Endotoxemia
Clin. Chem., October 1, 2006; 52(10): 1952 - 1957.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Suzuki, Y. Ito, K. Wakai, M. Kawado, S. Hashimoto, N. Seki, M. Ando, Y. Nishino, T. Kondo, Y. Watanabe, et al.
Serum heat shock protein 70 levels and lung cancer risk: a case-control study nested in a large cohort study.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1733 - 1737.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. D. Bushnell, P. Hurn, C. Colton, V. M. Miller, G. del Zoppo, M. S.V. Elkind, B. Stern, D. Herrington, G. Ford-Lynch, P. Gorelick, et al.
Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group
Stroke, September 1, 2006; 37(9): 2387 - 2399.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. F. Elias, M. A. Robbins, M. M. Budge, P. K. Elias, S. L. Brennan, C. Johnston, Z. Nagy, and C. J. Bates
Homocysteine, Folate, and Vitamins B6 and B12 Blood Levels in Relation to Cognitive Performance: The Maine-Syracuse Study
Psychosom Med, July 1, 2006; 68(4): 547 - 554.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Paffen and M. P.M. deMaat
C-reactive protein in atherosclerosis: A causal factor?
Cardiovasc Res, July 1, 2006; 71(1): 30 - 39.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. Ziakas, S. Gavrilidis, G. Giannoglou, E. Souliou, K. Gemitzis, D. Kalampalika, M. A. Vayona, I. Pidonia, G. Parharidis, and G. Louridas
In-Hospital and Long-Term Prognostic Value of Fibrinogen, CRP, and IL-6 Levels in Patients with Acute Myocardial Infarction Treated with Thrombolysis
Angiology, May 1, 2006; 57(3): 283 - 293.
[Abstract] [PDF]


Home page
Psychosom. Med.Home page
T. W. McDade, L. C. Hawkley, and J. T. Cacioppo
Psychosocial and Behavioral Predictors of Inflammation in Middle-Aged and Older Adults: The Chicago Health, Aging, and Social Relations Study
Psychosom Med, May 1, 2006; 68(3): 376 - 381.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Y. Ma, J. A Griffith, L. Chasan-Taber, B. C Olendzki, E. Jackson, E. J Stanek III, W. Li, S. L Pagoto, A. R Hafner, and I. S Ockene
Association between dietary fiber and serum C-reactive protein.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 760 - 766.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. H. James, M. G. Jamison, M. S. Biswas, L. R. Brancazio, G. K. Swamy, and E. R. Myers
Acute Myocardial Infarction in Pregnancy: A United States Population-Based Study
Circulation, March 28, 2006; 113(12): 1564 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.
Psychosom Med, March 1, 2006; 68(2): 187 - 200.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. J. Shaw, C. N. Bairey Merz, C. J. Pepine, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S4 - S20.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Newall, A. D. Grayson, A. Y. Oo, N. D. Palmer, W. C. Dihmis, A. Rashid, and R. H. Stables
Preoperative White Blood Cell Count is Independently Associated With Higher Perioperative Cardiac Enzyme Release and Increased 1-Year Mortality After Coronary Artery Bypass Grafting
Ann. Thorac. Surg., February 1, 2006; 81(2): 583 - 589.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. Wakugawa, Y. Kiyohara, Y. Tanizaki, M. Kubo, T. Ninomiya, J. Hata, Y. Doi, K. Okubo, Y. Oishi, K. Shikata, et al.
C-Reactive Protein and Risk of First-Ever Ischemic and Hemorrhagic Stroke in a General Japanese Population: The Hisayama Study
Stroke, January 1, 2006; 37(1): 27 - 32.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S G Baidya and Q-T Zeng
Helper T cells and atherosclerosis: the cytokine web
Postgrad. Med. J., December 1, 2005; 81(962): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. A. Booth, N. R. Obeid, and B. R. Lucchesi
Activation of estrogen receptor-{alpha} protects the in vivo rabbit heart from ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2039 - H2047.
[Abstract] [Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
M. B. Clearfield
C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease
J Am Osteopath Assoc, September 1, 2005; 105(9): 409 - 416.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. E. Laaksonen, L. Niskanen, K. Nyyssonen, K. Punnonen, T.-P. Tuomainen, and J. T. Salonen
C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study
Eur. Heart J., September 1, 2005; 26(17): 1783 - 1789.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. G. Best, Y. Zhang, E. T. Lee, J.-L. Yeh, L. Cowan, V. Palmieri, M. Roman, R. B. Devereux, R. R. Fabsitz, R. P. Tracy, et al.
C-Reactive Protein as a Predictor of Cardiovascular Risk in a Population With a High Prevalence of Diabetes: The Strong Heart Study
Circulation, August 30, 2005; 112(9): 1289 - 1295.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Khera, D. K. McGuire, S. A. Murphy, H. G. Stanek, S. R. Das, W. Vongpatanasin, F. H. Wians Jr, S. M. Grundy, and J. A. de Lemos
Race and Gender Differences in C-Reactive Protein Levels
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 464 - 469.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P.-H. Huang, L.-C. Chen, H.-B. Leu, P. Y.-A. Ding, J.-W. Chen, T.-C. Wu, and S.-J. Lin
Enhanced Coronary Calcification Determined by Electron Beam CT Is Strongly Related to Endothelial Dysfunction in Patients With Suspected Coronary Artery Disease
Chest, August 1, 2005; 128(2): 810 - 815.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
U. J. F. Tietge, D. Pratico, T. Ding, C. D. Funk, R. B. Hildebrand, T. Van Berkel, and M. Van Eck
Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress
J. Lipid Res., August 1, 2005; 46(8): 1604 - 1614.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Inoue, T. Kato, T. Uchida, M. Sakuma, A. Nakajima, M. Shibazaki, Y. Imoto, M. Saito, S. Hashimoto, Y. Hikichi, et al.
Local Release of C-Reactive Protein From Vulnerable Plaque or Coronary Arterial Wall Injured by Stenting
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 239 - 245.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. B. Pepys
CRP or not CRP? That Is the Question
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1091 - 1094.
[Full Text] [PDF]


Home page
Diabetes CareHome page
D. E. King, A. G. Mainous III, B. M. Egan, R. F. Woolson, and M. E. Geesey
Fiber and C-Reactive Protein in Diabetes, Hypertension, and Obesity
Diabetes Care, June 1, 2005; 28(6): 1487 - 1489.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Arnaud, F. Burger, S. Steffens, N. R. Veillard, T. H. Nguyen, D. Trono, and F. Mach
Statins Reduce Interleukin-6-Induced C-Reactive Protein in Human Hepatocytes: New Evidence for Direct Antiinflammatory Effects of Statins
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1231 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. W. Zieske, R. P. Tracy, C. A. McMahan, E. E. Herderick, S. Homma, G. T. Malcom, H. C. McGill Jr, J. P. Strong, and for the Pathobiological Determinants of Atheroscle
Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1237 - 1243.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al.
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members
Stroke, June 1, 2005; 36(6): 1316 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Lo, R. Fijnheer, A. P. Nierich, P. Bruins, and C. J. Kalkman
C-Reactive Protein is a Risk Indicator for Atrial Fibrillation After Myocardial Revascularization
Ann. Thorac. Surg., May 1, 2005; 79(5): 1530 - 1535.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Kovacs, P. Henriksson, A. Hamsten, H. Wallen, J. Bjorkegren, and P. Tornvall
Hormonal Regulation of Circulating C-Reactive Protein in Men
Clin. Chem., May 1, 2005; 51(5): 911 - 913.
[Full Text] [PDF]


Home page
Diabetes CareHome page
Y. Doi, Y. Kiyohara, M. Kubo, Y. Tanizaki, K. Okubo, T. Ninomiya, M. Iwase, and M. Iida
Relationship Between C-Reactive Protein and Glucose Levels in Community-Dwelling Subjects Without Diabetes: The Hisayama Study
Diabetes Care, May 1, 2005; 28(5): 1211 - 1213.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. B. Kritchevsky, M. Cesari, and M. Pahor
Inflammatory markers and cardiovascular health in older adults
Cardiovasc Res, May 1, 2005; 66(2): 265 - 275.